During the past decade, Centre Léon Bérard conducted 667 clinical trials. In the 10-year time frame, 667 clinical trials started and 119 clinical trials were completed, i.e. on average, 17.8% percent of trials that started reached the finish line to date. In the past 5 years, 329 clinical trials started and 80 clinical trials were completed. i.e. 24.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Léon Bérard" #1 sponsor was "Centre Leon Berard" with 146 trials, followed by "UNICANCER" with 108 trials sponsored, "Hoffmann-La Roche" with 62 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 59 trials sponsored and "The Lymphoma Academic Research Organisation" with 59 trials sponsored. Other sponsors include 602 different institutions and companies that sponsored additional 218 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Léon Bérard" #1 collaborator was "National Cancer Institute, France" with 37 trials as a collaborator, "AstraZeneca" with 25 trials as a collaborator, "Merck Sharp & Dohme LLC" with 24 trials as a collaborator, "Bristol-Myers Squibb" with 17 trials as a collaborator and "Pfizer" with 16 trials as a collaborator. Other collaborators include 642 different institutions and companies that were collaborators in the rest 358 trials.

According to Clinical.Site data, the most researched conditions in "Centre Léon Bérard" are "Breast Cancer" (70 trials), "Ovarian Cancer" (29 trials), "Prostate Cancer" (29 trials), "Colorectal Cancer" (24 trials) and "Cancer" (23 trials). Many other conditions were trialed in "Centre Léon Bérard" in a lesser frequency.

Most popular intervention types in "Centre Léon Bérard" are "Drug" (756 trials), "Other" (115 trials), "Radiation" (99 trials), "Procedure" (96 trials) and "Biological" (81 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (60 trials), "Paclitaxel" (34 trials), "Atezolizumab" (33 trials), "Carboplatin" (32 trials) and "Bevacizumab" (31 trials). Other intervention names were less common.

The vast majority of trials in "Centre Léon Bérard" are 791 trials for "All" genders, 155 trials for "Female" genders and 63 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Léon Bérard". 10 are not yet recruiting, 278 are recruiting, 172 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 407 completed trials in Centre Léon Bérard, 4 suspended trials, and 89 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Léon Bérard, 164 "Phase 1" clinical trials were conducted, 421 "Phase 2" clinical trials and 301 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 123 trials that are defined as “Not Applicable".

Centre Léon Bérard has several departments that took part in Clinical trials: "CENTRE LEON BERARD; Département d'Hématologie et d'Oncologie" - 8 trials, "Centre Léon Bérard - Service d'oncologie médicale" - 4 trials, "Centre Leon Berard; Oncologie Genetique" - 3 trials, "Centre Léon Bérard - Hématologie" - 6 trials